OBJECTIVE: The apolipoprotein E (APOE) gene is an established risk factor for sporadic Alzheimer's disease, with elevated risk for ε4-carriers and reduced risk for ε2-carriers. However, it is unclear whether APOE modifies risk for cognitive decline in normal aging. The objective of this study was to determine whether ε2 and ε4 are associated with rates of normal cognitive aging, and whether associations of ε4 with cognitive decline are modified by sex, education or health behaviors (exercise, alcohol consumption, smoking). METHOD: A community-based sample of 1,393 older adults were genotyped for APOE and underwent cognitive assessment up to seven times over a maximum of period of 27 years. RESULTS: ε2-carriers showed slower executive function decline with age relative to ε3 homozygotes or ε4-carriers, whereas ε4-carriers demonstrated more rapid executive function and verbal fluency decline. Accelerated executive function decline was particularly pronounced in ε4-carriers with lower education. After excluding individuals with cognitive impairment, faster executive function decline was still apparent in ε4-carriers, and the effect of ε4 on episodic memory interacted with alcohol consumption, such that only ε4-carriers who did not drink showed more rapid memory decline than ε4 noncarriers. The influence of ε4 on cognitive aging did not differ by sex, nor was it modified by smoking or exercise. CONCLUSIONS: These findings indicate that the ε2 and ε4 alleles have differential effects on cognitive aging, and that negative effects of ε4 may be partly mitigated by behavioral choices. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
OBJECTIVE: The apolipoprotein E (APOE) gene is an established risk factor for sporadic Alzheimer's disease, with elevated risk for ε4-carriers and reduced risk for ε2-carriers. However, it is unclear whether APOE modifies risk for cognitive decline in normal aging. The objective of this study was to determine whether ε2 and ε4 are associated with rates of normal cognitive aging, and whether associations of ε4 with cognitive decline are modified by sex, education or health behaviors (exercise, alcohol consumption, smoking). METHOD: A community-based sample of 1,393 older adults were genotyped for APOE and underwent cognitive assessment up to seven times over a maximum of period of 27 years. RESULTS: ε2-carriers showed slower executive function decline with age relative to ε3 homozygotes or ε4-carriers, whereas ε4-carriers demonstrated more rapid executive function and verbal fluency decline. Accelerated executive function decline was particularly pronounced in ε4-carriers with lower education. After excluding individuals with cognitive impairment, faster executive function decline was still apparent in ε4-carriers, and the effect of ε4 on episodic memory interacted with alcohol consumption, such that only ε4-carriers who did not drink showed more rapid memory decline than ε4 noncarriers. The influence of ε4 on cognitive aging did not differ by sex, nor was it modified by smoking or exercise. CONCLUSIONS: These findings indicate that the ε2 and ε4 alleles have differential effects on cognitive aging, and that negative effects of ε4 may be partly mitigated by behavioral choices. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
Authors: Kenneth J Mukamal; Lewis H Kuller; Annette L Fitzpatrick; W T Longstreth; Murray A Mittleman; David S Siscovick Journal: JAMA Date: 2003-03-19 Impact factor: 56.272
Authors: Tianqi Li; Colleen Pappas; Scott T Le; Qian Wang; Brandon S Klinedinst; Brittany A Larsen; Amy Pollpeter; Ling Yi Lee; Mike W Lutz; William K Gottschalk; Russell H Swerdlow; Kwangsik Nho; Auriel A Willette Journal: Neurobiol Aging Date: 2021-09-30 Impact factor: 4.673
Authors: Sarayu Ramakrishna; Vishwaja Jhaveri; Sabine C Konings; Bharti Nawalpuri; Sumita Chakraborty; Bjørn Holst; Benjamin Schmid; Gunnar K Gouras; Kristine K Freude; Ravi S Muddashetty Journal: J Neurosci Date: 2021-09-02 Impact factor: 6.167
Authors: Éimear M Foley; Yorghos Tripodis; Eukyung Yhang; Inga K Koerte; Brett M Martin; Joseph Palmisano; Nikos Makris; Vivian Schultz; Chris Lepage; Marc Muehlmann; Paweł P Wróbel; Jeffrey P Guenette; Robert C Cantu; Alexander P Lin; Michael Coleman; Jesse Mez; Sylvain Bouix; Martha E Shenton; Robert A Stern; Michael L Alosco Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.160
Authors: Aziz M Mezlini; Colin Magdamo; Emily Merrill; Lori B Chibnik; Deborah L Blacker; Bradley T Hyman; Sudeshna Das Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Riki E Slayday; Daniel E Gustavson; Jeremy A Elman; Asad Beck; Linda K McEvoy; Xin M Tu; Bin Fang; Richard L Hauger; Michael J Lyons; Ruth E McKenzie; Mark E Sanderson-Cimino; Hong Xian; William S Kremen; Carol E Franz Journal: J Int Neuropsychol Soc Date: 2020-07-14 Impact factor: 2.892
Authors: Emma Rhodes; Philip S Insel; Meryl A Butters; Ruth Morin; David Bickford; Duygu Tosun; Devon Gessert; Howie J Rosen; Paul Aisen; Rema Raman; Susan Landau; Andrew Saykin; Arthur Toga; Clifford R Jack; Michael W Weiner; Craig Nelson; Scott Mackin Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: R Martin-Willett; B Morris; R Wilcox; G Giordano; J Andrews-Hanna; M Banich; A B Bryan Journal: Exp Gerontol Date: 2021-05-29 Impact factor: 4.253